Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer

SIMPLE SUMMARY: Several studies suggested an enhanced efficacy of conventional treatments (CT, i.e., chemotherapy +/− targeted therapy) administered after immune checkpoint inhibitors (ICI) in certain tumor types, but no data are available concerning metastatic colorectal cancer (mCRC) patients harb...

Descripción completa

Detalles Bibliográficos
Autores principales: Bui, Quang Loc, Mas, Léo, Hollebecque, Antoine, Tougeron, David, de la Fouchardière, Christelle, Pudlarz, Thomas, Alouani, Emily, Guimbaud, Rosine, Taieb, Julien, André, Thierry, Colle, Raphaël, Cohen, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774125/
https://www.ncbi.nlm.nih.gov/pubmed/35053568
http://dx.doi.org/10.3390/cancers14020406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774125/
https://www.ncbi.nlm.nih.gov/pubmed/35053568
http://dx.doi.org/10.3390/cancers14020406

Ejemplares similares